Once again we need to make assumptions and the unknown will keep the pps down. Does the latest news effect the S-1 / Funding or is this part of the strategy to keep traders guessing? Maybe the company should just concentrate on clinical trials , at least positive updates will move the pps without making unattainable goals and missed duediligence!!